The American Stock Exchange lists the common stock of Xcorporeal, Inc. under the ticker symbol XCR.
Xcorporeal, Inc. is a medical device company developing an innovative extra-corporeal platform technology that may be used in devices to replace the function of various human organs. The platform will lead to three initial products; a device for home hemodialysis, another device for hospital Renal Replacement Therapy (RRT) and the Wearable Artificial Kidney (WAK) for continuous ambulatory hemodialysis.
These devices will seek to provide patients with improved, efficient and cost effective therapy. The RRT markets represent multibillion dollar opportunities.
“We are pleased to welcome Xcorporeal, Inc to the American Stock Exchange,” said Neal Wolkoff, Chairman and CEO of Amex. “We look forward to working with Xcorporeal and building strong relationships within the investment community to enhance their growth in the marketplace.”
The specialist for Xcorporeal, Inc is Cohen Specialist LLC. -- www.amex.com
Comment and add to the story without registration, but keep the comments meaningful please. Links are not accepted.
